WHO
Global campaign to reduce cholera deaths by 90%
October 4, 2017Medical Communications, Research and Development Cholera, WHO, biotech, drugs, pharma, pharmaceutical
A new campaign, launched by the WHO, has begun today to reduce deaths from cholera by 90% through to 2030. …
Measles eradicated in the UK, according to WHO
September 28, 2017Medical Communications UK, WHO, biotech, drugs, measles, pharma, pharmaceutical
The measles virus has been eliminated from the UK for the first time in the country’s history, according to the …
Antibiotic development is inadequate to meet global resistance threat, WHO warns
September 20, 2017Research and Development WHO, antibiotic resistance, antimicrobial resistance, pharma, pharmaceutical, world health organization
The World Health Organization (WHO) has released a report indicating that worldwide development of new antibiotics is not keeping pace …
Hope in quest for gonorrhoea vaccination
July 11, 2017Manufacturing and Production, Research and Development WHO, gonorrhoea, meningitis, vaccination
Only last week, the WHO expressed serious concerns about the possibility of strains of gonorrhoea developing that could be resistant …
Bhutan and Maldives successfully eliminate measles
June 14, 2017Medical Communications, Research and Development WHO, immunisation, measles, rubella
The WHO has announced that Bhutan and Maldives have become the first South-East Asia region countries to successfully eliminate measles. …
WHO elects first African Director General
May 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, appointment
Ethiopian-born Tedros Adhanom Ghebreyesus has been announced as the Next Director General of the World Health Organization (WHO) after securing …
Tedros Adhanom Ghebreyesus becomes WHO Director General
May 25, 2017Medical Communications WHO
Ethiopian-born Tedros Adhanom Ghebreyesus has been announced as the Next Director General of the World Health Organization (WHO) after securing …
WHO aims to increase uptake of biosimilars in poorer countries
May 4, 2017Medical Communications, Research and Development Cancer, Roche, WHO, biosimilars
The WHO has announced that it will launch a project to prequalify biosimilar medicines for the treatment of certain cancers. …
Five crucial facts about mental health
April 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, anxiety, depression, mental health, world health day
7 April marked this year’s World Health Day, and for 2017 the WHO selected depression as the annual focus. Prevalent …
WHO releases list of bacteria that pose greatest threat to humankind
February 28, 2017Research and Development WHO, antibiotic resistance
The World Health Organisation (WHO) has published a list of the 12 bacteria that are thought to present the largest …
African Heads of State commit to universal access to immunisation
February 1, 2017Medical Communications, Research and Development Africa, Vaccine, WHO, immunisation
The Heads of State convened from across Africa to ratify the Addis Declaration on Immunization (ADI). The pledge commits to …
Male birth control injection has high efficacy but side-effects halt trials
October 28, 2016Medical Communications WHO, birth control, male contraceptive, pregnancies
The study, funded by the World Health Organization, found a jab was close to 96% effective in tests to ascertain …
Janssen’s New Drug Application for drug to treat intestinal worms gets US FDA priority review
July 14, 2016Manufacturing and Production, Research and Development, Sales and Marketing Johnson & Johnson, US FDA, WHO, drug trial, new drug application, regulation, soil-transmitted helminthiasis
Johnson & Johnson (NYSE: JNJ) said the US Food and Drug Administration (FDA) has granted Priority Review for its New …
FDA, WHO criticise integrity of data at contract research firm Semler
April 25, 2016Research and Development, Sales and Marketing FDA, India, WHO, World Health Organisation, semler, semler research
The US Food and Drug Administration and the World Health Organisation have raised serious concerns related to violations of good …
MSD and GAVI agree Ebola vaccine deal
January 20, 2016Manufacturing and Production, Research and Development Ebola, GAVI, MSD, WHO
MSD and the global vaccine alliance Gavi have agreed a deal to provide 300,000 dosesof an Ebola virus vaccine, to …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
